|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 11/18/14 Bellicum Pharmaceuticals, Inc S-1 40:9.7M RR Donnelley/FA |
Document/Exhibit Description Pages Size 1: S-1 Registration Statement (General Form) HTML 1.49M 2: EX-3.1 Articles of Incorporation/Organization or By-Laws HTML 131K 3: EX-3.2 Articles of Incorporation/Organization or By-Laws HTML 32K 4: EX-3.3 Articles of Incorporation/Organization or By-Laws HTML 97K 5: EX-3.4 Articles of Incorporation/Organization or By-Laws HTML 113K 6: EX-4.2 Instrument Defining the Rights of Security Holders HTML 330K 7: EX-4.3 Instrument Defining the Rights of Security Holders HTML 55K 8: EX-4.4 Instrument Defining the Rights of Security Holders HTML 46K 9: EX-4.5 Instrument Defining the Rights of Security Holders HTML 71K 10: EX-10.1 Material Contract HTML 59K 19: EX-10.10 Material Contract HTML 93K 20: EX-10.11 Material Contract HTML 18K 21: EX-10.12 Material Contract HTML 99K 22: EX-10.13 Material Contract HTML 99K 23: EX-10.14 Material Contract HTML 14K 24: EX-10.15 Material Contract HTML 173K 25: EX-10.16 Material Contract HTML 104K 26: EX-10.17 Material Contract HTML 74K 27: EX-10.18 Material Contract HTML 110K 28: EX-10.19 Material Contract HTML 208K 11: EX-10.2 Material Contract HTML 75K 29: EX-10.20 Material Contract HTML 138K 30: EX-10.21 Material Contract HTML 359K 31: EX-10.22 Material Contract HTML 35K 32: EX-10.23 Material Contract HTML 40K 33: EX-10.24 Material Contract HTML 27K 34: EX-10.25 Material Contract HTML 45K 35: EX-10.26 Material Contract HTML 39K 36: EX-10.27 Material Contract HTML 155K 37: EX-10.28 Material Contract HTML 21K 38: EX-10.29 Material Contract HTML 17K 12: EX-10.3 Material Contract HTML 132K 13: EX-10.4 Material Contract HTML 251K 14: EX-10.5 Material Contract HTML 19K 15: EX-10.6 Material Contract HTML 99K 16: EX-10.7 Material Contract HTML 99K 17: EX-10.8 Material Contract HTML 88K 18: EX-10.9 Material Contract HTML 23K 39: EX-16.1 Letter re: Change in Certifying Accountant HTML 12K 40: EX-23.1 Consent of Experts or Counsel HTML 11K
| EX-16.1 |
Exhibit 16.1
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street NE
Washington, DC 20549
Dear Sir/Madam:
We have read the statements included under Form S-1, dated November 18, 2014, of Bellicum Pharmaceuticals, Inc. (the “Company”) to be filed with the Securities and Exchange Commission, and we agree with such statements insofar as they relate to our dismissal and our audits for the years ended December 31, 2013 and 2012. We cannot confirm or deny that the appointment of Ernst and Young, LLP was approved by the Company’s Board of Directors.
Very truly yours,
| This ‘S-1’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/18/14 | None on these Dates | ||
| 12/31/13 | ||||
| 12/31/12 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/28/23 Bellicum Pharmaceuticals, Inc. 10-K/A 12/31/22 2:389K Workiva Inc Wde… FA01/FA 3/31/23 Bellicum Pharmaceuticals, Inc. 10-K 12/31/22 66:6.9M Workiva Inc Wde… FA01/FA 3/24/22 Bellicum Pharmaceuticals, Inc. 10-K 12/31/21 71:8.4M Workiva Inc Wde… FA01/FA 3/31/21 Bellicum Pharmaceuticals, Inc. 10-K 12/31/20 69:8.7M Workiva Inc Wde… FA01/FA 11/05/20 Bellicum Pharmaceuticals, Inc. 10-Q 9/30/20 66:9M 8/06/20 Bellicum Pharmaceuticals, Inc. S-8 8/06/20 3:148K 8/06/20 Bellicum Pharmaceuticals, Inc. 10-Q 6/30/20 60:7.1M 12/03/14 SEC UPLOAD¶ 9/13/17 1:158K Bellicum Pharmaceuticals, Inc. |